国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation...

12
397 国立医薬品食品衛生研究所報告 Arcobcater 254 Aristolochic acid 240, 242 Ascofuranone 215 Asparagus racemosus 169 astrocyte 223 Atherosclerosis 212 ATR 162 ATRA 213 augmented reality 182 B bean 189 Benchmark dose approach 264 benzylpiperazine BZP174 BHA 180 bimetallic catalysis 211 Bioanalysis 247 bioanalytical method validation 247 biodegradable polymers 182 bioequivalence guidelines 1 Biolm 201 biomarker 260 bioreactor 50 Biosimilar 167 Biotechnology 167 bitter melon 232 black tea 208 bladder toxicity 228 blood urea nitrogen 205 bovine offal 196 broiler 207 Buckwheat 214 Burden of foodborne illness 218 C caffeic acid 236 calcitriol 231 CALUX 189 Campylobacter 196, 254 Capillary liquid chromatography 163 Capsaicin 239 carbendazim 187 carbon monoxide 193 A ABCA1 211, 212, 213 ABINIT-MP X220 abortive branching 191 acetaminophene 208 Acid resistance 195 acrylamide 234 acyltransferase 175 adaptive response 238 adipogenesis 224 Aatoxin M 1 204 aggregates 43 Aggregation 215 aging 223 agricultural products 187 Ah receptor 189 aildenal prodrug 209 alkali fusion 194 allele frequencies 260 Allergen 214 allergenic hazards 182 allylation 211 alpha-1-acid glycoprotein 162 ALS 261 alternative methods 245 Aluminium ammonium sulfate 243 amino acids 209, 210 aminoadipate reductase gene 202, 203 amiodarone 219 amorphous 161 Anaphylaxis 214 Anaphylaxy 258 angiotensin II 176, 180 animal and shery product 187, 189 animal experiments 245 Annual Change 205 antibiotics 195 antimicrobial resistance 195, 207 antioxidant 209, 230 Antiviral activity 216 antiviral drugs 165, 250 Apple 217 aquatic environment 185 Aquilaria 169 国立医薬品食品衛生研究所報告第130号キーワード索引(アルファベット順)

Transcript of 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation...

Page 1: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

397国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

Arcobcater 254Aristolochic acid 240, 242Ascofuranone 215Asparagus racemosus 169astrocyte 223Atherosclerosis 212ATR 162ATRA 213augmented reality 182

B

bean 189Benchmark dose approach 264benzylpiperazine (BZP) 174BHA 180bimetallic catalysis 211Bioanalysis 247bioanalytical method validation 247biodegradable polymers 182bioequivalence guidelines 1Biofilm 201biomarker 260bioreactor 50Biosimilar 167Biotechnology 167bitter melon 232black tea 208bladder toxicity 228blood urea nitrogen 205bovine offal 196broiler 207Buckwheat 214Burden of foodborne illness 218

C

caffeic acid 236calcitriol 231CALUX 189Campylobacter 196, 254Capillary liquid chromatography 163Capsaicin 239carbendazim 187carbon monoxide 193

A

ABCA1 211, 212, 213ABINIT-MP(X) 220abortive branching 191acetaminophene 208Acid resistance 195acrylamide 234acyltransferase 175adaptive response 238adipogenesis 224Aflatoxin M1 204aggregates 43Aggregation 215aging 223agricultural products 187Ah receptor 189aildenafil prodrug 209alkali fusion 194allele frequencies 260Allergen 214allergenic hazards 182allylation 211alpha-1-acid glycoprotein 162ALS 261alternative methods 245Aluminium ammonium sulfate 243amino acids 209, 210aminoadipate reductase gene 202, 203amiodarone 219amorphous 161Anaphylaxis 214Anaphylaxy 258angiotensin II 176, 180animal and fishery product 187, 189animal experiments 245Annual Change 205antibiotics 195antimicrobial resistance 195, 207antioxidant 209, 230Antiviral activity 216antiviral drugs 165, 250Apple 217aquatic environment 185Aquilaria 169

国立医薬品食品衛生研究所報告第130号キーワード索引(アルファベット順)

Page 2: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)398 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

Critical Quality Attribute 248cross-contamination 196Crustaceans 217crystallization 161crystal structure 203Curriculum 245cyanogen 189cynomolgus macaque 183CYP2C8 219cytochrome P450 236cytotoxicity 200, 263

D

daily intake 193Daiokanzoto 171D-amino acid 176D-Amino acid oxidase 176DC-SIGN 166decabromodiphenyl ether 226decocting machine 171delayed adverse effect 230dentate gyrus 234DES 230designer drug 173Detecting method 257detection 190, 192, 201, 253detection method 254detergent 194Determination 205developmental neurotoxicity 234developmental toxicity 226, 261Dextran 216dielectric relaxation time 161Dietary oil emulsion 214dilated cardiomyopathy 179dimethyl fumarate 186diol 211dioxin 188, 189direct analysis in real time 174discrimination method 172Dissolution 246dissolution profiles 1DMSO 159DNA adduct 231, 242DNA analysis 169DNA damage 230

carbon tetrachloride 71carcinogenesis 184carcinogenicity 227carcinosarcoma 232cardiac differentiation 179Cardiolipin 175Cassia acutiforia 171Cassia angustifolia 171catechin 209catechin mixture 227CEA 166C. elegans 168, 175, 176CGH 180Chemical Imaging 162, 248chemoprevention 238, 239chirality 210chiral separation 173CHL cells 217chlorogenic acid 236Chromatin reorganization 221Chromosome aberrations 217chromosome aberration test 263Chromosome aberration test 217chronic toxicity 227cigarette smoke 236clinical pharmacology 245clofencet 187clofibric acid 242Clostridium perfringes enterotoxin 203c-Met 167Codex 253collaborative study 194collagen vitrigel membrane 184colon cancer 168colony hybridization 204comet assay 180complement fragments 224conformation 209contact dermatitis 186contamination 195contamination level 200convulsion 227corpora lutea 229Counterpoise 220creatinine 205CREB 224CRIg 224

Page 3: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

399国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

FDA 248Feline calicivirus 216Fertilization 166filamin 181fish 188flavonol glycoside 170FLC-4 cells 165Flounder 207fluoride 205fluorination 211FMO 220FMO4 221FMO-CC 220FMO-MP2 221Follicular growth 205Follow-on biologics 167food additive 71, 193Food additive 243food additives 46, 193Food allergen 257food allergy 253Food allergy 58, 217, 257food analysis 21Food analysis 252Food-borne 254foodborne infections 200food chain 50FoodNet 259food outbreak 196Food poisoning 207Food poisoning by raw beef 253food poisoning statistics 255food safety 196Food safety 245freeze-drying 160, 247Freeze-drying 247fruit 203fucosylation 168fullerenes 185fulminant hepatitis 66fungal contamination 203Fungal contamination 202Furniture made from Kiri (Paulownia tomentosa) 202Fusarium 202Fusarium phylogeny 203

DNA demethylation 222dopamine agonist, 218DOXIL 247Doxorubicin 163, 164drinking water 238Drinking water 258drug classes 66drug-induced liver injury 66dynamic light scattering 43

E

Education 245electroencephalogram 172electron spin resonance 230Eleutherococcus senticosus 169elevation 208ELISA 207EMA 248embryonic stem cell 179Endocytosis 163endoplasmic reticulum 242Enterobacteriaceae 253, 255enterohemorrhagic E. coli (EHEC) 196entry inhibitor 165, 250enumeration 203enzymatically modified isoquercitrin 235enzyme-assisted synthesis 208Epidemiological data 264epidermis 237erythropoiesis 223Erythropoietin 167Escherichia coli 204, 207Estimation 252estimation of intake 190estragole 231estrogenic activity 170ethnic difference 260ethylene glycol monomethyl ether 229, 235European Food Safety Authority (EFSA) 264evectin-2 174event-specific 191Expert review 218

F

F344 rats 228, 230

Page 4: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)400 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

headspace GC-FID 194Health Science 245helical structures 210helicity 210Helicobacter pylori 226helix 209hepatic expression 211Hepatitis A 197hepatitis C 158Hepatocarcinogen 244hepatocarcinogenesis 231, 233, 234hepatocellular hypertrophy 228hepatocytes 159hepatotoxicity 158, 208HGF 167hinokitiol 230Histone methylation 222Histone modification 221HIV 183HIV-1 165, 250HL60 180HNF4α 213honeycombs 181horseradish extract 228household product 186household products 186HPLC 204HPLC-fluorescence detection 174human 159human leukocyte antigen (HLA) 260Human tissue 245Hydration 161

I

IAP 211ICATM 261ICH 251, 263, 264IgE 258IgY 207image overlay system 182Immune-proteomics 214immunochromatography kit 201imported foods 195impurity 1indole-3-carbinol 229, 233infectious dose 200

G

GADD45 228GC-FID 193GC/MS 189gene expression 158, 159gene mutation 237generic products 1genetically modified (GM) 191, 192genetically modified maize 190Genetically modified organism 215Genetically modified organism (GMO) 192genetic polymorphism 260genetic polymorphisms 219, 260Genistein 222genotoxicity 238, 240genotype 197genotyping 195, 219germline development 168GHS 218GII/14 199Ginkgo biloba 170GlcNAcylation 221glomerulonephritis 205glucuronide 208glutathione-S-transferase 219Glycerol 215Glycerol kinase 215glycoprotein pharmaceuticals 164GM fish and animal 50GPI-anchor 168gpt delta 236gpt delta 233gpt delta transgenic rat 238, 239, 240Granulation process 247Ground chicken meat 254group testing 192growth variation 191guidance on evaluation of medical devices with emerging

technology 13

H

haplotype 219harmful element 186HCP 249HDX/MS 166

Page 5: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

401国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

Listeria 195Listeria monocytogenes 195, 254listeriosis 254liver 213liver hypertrophy 228liver-specific functions 165liver tumor promotion 228livestock product 188locomotor activity 172long-term depression 224LS/MS 205LSPA6 genotype 200LXR 212

M

Mac-2BP 166main server system 75Mandatory labeling 257market basket method 193mast cell 223maternal exposure 226measurement uncertainty 21Measurement uncertainty 252meat 191medium-term animal model 233mesenchymal stem cells 224Metabolite 163metabolomics 171, 208, 260methanol 194method validation 21methylation 180, 226Micobiological risk management 253microbial interaction 206microbiological criteria 254, 255microgravity 241micronucleus 237micronucleus test 241, 263microRNA 181microscopy 161microwave 211MIG12 212misleading positive results 262mismatch repair 238mitochondria 175mode of action (MOA) 263mold-proof 186

inflammation 226inflammatory response 160In silico 159insulin 166, 209inter-laboratory study 164internal quality control 21International Space Station (ISS) 241intestinal macrophage 224Intracellular trafficking 163in vitro 225in vitro genotoxicity 263in vitro genotoxicity testing 262In vitro tests 217in vivo genotoxicity 239, 241irradiated food 189ISO/IEC 17025 252

J

JaCVAM 261Japanese guideline 247

K

Keap1/Nrf2 system 183Kodoa septempunctata 207Kudoa 256Kudoa septempunctata 256Kuguacin J 232

L

labeling 253Labeling 257Lac-CY-SF 165Lactose 58lamella layer 225LAMP 201LC-MS 173, 187, 189, 192LC-MS/MS 185, 186, 187, 188leguminoseae 170Leucine-rich repeat kinease-2 215L-glutamate transporter 223Light scattering detection 163lipogenesis 212liposome 161Liposomes 163

Page 6: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)402 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

O

ochratoxin A 236OECD 265Ointment 162old yellow enzyme 173oleic acid 242oligomeric stability 166Oral-immunity 258organocatalyst 209oseltamivir 185oseltamivir carboxylate 185oxfendazole 234oxidative stress 209, 234

P

p53 237P450 158paclitaxel 162Papaya 215Parkinson’s disease 218Partial geometry optimization 221PAT 247PCR 201, 217PCR-RFLP 169Peach 217peptide 209, 210peptide nucleic acid 210perfluorooctadecanoic acid 243Peroxiredoxin 6 183peroxynitrate 208Peyer’s patch 196PFOS 227Pharmaceutical excipient 58Pharmacist 245Pharmacoepidemiology 260pharmacogenomics 162, 260Pharmacokinetics 163Pharmacology 245Pharmacopeia 246phase separation 160phenobarbital 235PHF2-ARID5B complex 222phosphatidylinositol 175phosphatidylserine 174phosphodiesterase 176, 180

mold-ripened cheese 206molecularepidemiology 197molecular phylogenetic alanalysis 202Mongolian gerbil 232monoclonal antibody product 43Monolithic column 162monosaccharide composition analysis 164Morus bombycis 193mouse 196, 205mulberry bark extract 193multiplex real-time PCR 190, 204multivariate analysis 208Multi-wall carbon nanotube 243mutagenicity 236, 240, 242mutaprodenafil 209mutation 241MX 238mycoflora 203Myristoylation 216

N

N-acetyl-L-cysteine 229NAD(P)H oxidase 224Nanomaterial 243Nanoparticles 162Nano-Suspensions 181National Epidemiological Surveillance of Foodborne Disease 

255negative regulator 181neonatal exposure 230neopterin 223network system 75neurotoxicity 227, 234nickel subsulfide 240NIHS-NET 75NIR 247nitric oxide 208nitrobenzene 208NMDA receptor 228NMR 171NMR relaxation time 161non-genotoxic hepatocarcinogen 228non-secosteroidal ligand 210nuclear receptor 158, 213

Page 7: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

403国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

Q

QbD 247qNMR 251QSAR 158quality 208quality assurance 21Quality assurance 252Quality by Design 248quality reevaluation 1quantification 46, 192, 204quantitative NMR 171, 185

R

radiation 241Radiation 258Radionuclides 258rat 159raw meat 255reactive oxygen species 179, 229, 233, 235real-time PCR 191, 206reconstructed cultured human skin model 225reconstructed human epidermis 225recycling endosomes 174reduction animal use 262reference molecule 191regional difference 196regulatory science 13reliability 185repeated dose toxicity 243reporter gene assay 188reports of adverse reactions 66reproductive and developmental toxicity 243research 245resistance 195resistance to microorganisms 50reticulocyte 239retrograde membrane traffic 174Rice 214rodenticide 186, 187, 188

S

safety evaluation 261safety information 218safrole 233

Phospholipase A2 183phospholipidosis 160phthalate 194Phthalate substitute 31Phthalic acid diester and monoester 186phylogenetic species concept 202PI3K/Akt signaling 231PI3K pathway 231Pig-a assay 239pindone 186, 188plasticizer 194Plasticizer 31Polymerase chain reaction 215polyvinyl chloride 186polyvinyl chloride (PVC) 194population differences 260pore-forming 203poly L-lysine 216positive selection 203poultry processing 196PPARgamma 212prediction 159, 160Prediction 158predictive capacity 262preorganization 210principal component analysis 209Process Analytical Technology 248processed aconite root 172progesterone 235prostaglandin synthase 173prostate cancer 232Proteasome 166Protein 161protein formulation 247Protein kinase A 222protein kinase C 224protein knockdown 211, 213proteomics 261Proteomics 214psilocin 208punch test 182purity 185purity test 71Purkinje cells 224pyridine carbonate-pyrazolone method 189

Page 8: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)404 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

stem cell factor 223Stemona plants 169Steroidogenic factor 1 222Stevens-Johnson syndrome 260stx genotype 200subchronic toxicity 230Sugihiratake 191sulfadimethoxine 231sulpiride 235supply 245supramammillary nucleus 226surveillance system of infectious diseases 255Survival 201synthetic cannabinoid 173synthetic cannabinoids 172, 173synthetic resin 186systems biology 159

T

tablet PC 182tamoxifen 211Tamoxifen 223taste evaluation 172TBHQ 180Telephone Survey 218tensile property 182Teratogenicity 243TESSy 259Test concentration limit 217testicular toxicity 234test methods for biological safety evaluation of medical

devices 13the Japanese Pharmacopoeia 171thermal analysis 247thiabendazole 46thyroid carcinogenesis 231thyroid follicular cell carcinomas 231time-of-flight mass spectrometry 174tissue distribution 185titanium dioxide 184, 194titration 46TLC 192Tolerance 258Toll-like receptor-9 160total diet study 190toxic epidermal necrolysis 260

Salicylic acid 214salivary gland 232Salmonella 201Salmonella 195, 254, 255Sarcocystis fayeri 256screening 192Screening 244screw-sense control 210security countermeasures 75self-grooming behavior 226senna 171Setsucha 171Shiga toxin-producing E. coli (STEC) 196Shiga toxin-producing Escherichia coli 201Shiga toxin-producing Escherichia coli O157 200, 206SigB 195sildenafil analogue 209Silica 181silicate 194silicone resin 71Silver 181Silymarin 238simulation model 196Size exclusion chromatography 162skin 184Skin irritation 225skin morphology 225skin permeation 225skin sensitization test 182, 184smooth muscle cells 181sodium nitrite 236sodium stearoyl lactylate 192solid-phase synthesis 211Somatropin 167species identification 169Specification 246Sperm 166spinosad 189Stability 161stabilization 160standard 185standard for approval review 13Standard for raw beef 253Standard method 255Staphylococcal enterotoxin 207stapled peptide 209statin 211

Page 9: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

405国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

W

Weight of evidence 218weight of evidence (WOE) 263Wistar Hannover GALAS rat 232Wnt signalling 179

X

xenotransplantation 50Xerophilic fungi 202X-ray crystallographic analysis 210X-ray structure 173

Y

yeast two-hybrid assay 170

Z

Zinc Oxide 181

1,2-Naphthoquinone 1831-(3-trifluoromethylphenyl)piperazine (TFMPP) 1741H-NMR 2092-(2-methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)

methyl]-1H-indol-3-yl}ethanone 1732,4-diaminotoluene 2402,6-diaminotoluene 2402-alkylcyclobutanone 1893D human skin model 1844-hydroxycoumarin 1875-bromo-2’-deoxyuridine 2298-hydroxydeoxyguanosine containing DNA 160

DDS製剤 248ELISA法 258(−)-epigallocatechin gallate 200

GHS分類 259HPVプログラム 265non-O157志賀毒素産生性大腸菌(STEC) 219PFGE試験 256(Q)SAR 241

SIDS初期評価会議 265Ti-Zr-Nb合金 181

toxicogenomics 158, 159, 160Toxicogenomics 159, 244Toxicological information 31toy 194Transcriptional activation 164Transcription factor 164trans-fat 190Transfection 164transforming growth factor-beta 223transient receptor potential canonical 176, 180transient receptor potential channel 179Transporter 163trichothecene 200Trichothecene mecotoxins 205TRIMCyp 183trnK intron sequence 169TrpCage 221Two-generation reproductive/developmental toxicity 243tyrosine phosphorylation 167

U

ubiquitin 211, 213ubiquitin-proteasome system 211UHMWPE 182UJNR 256Ultrasound 164undifferentiated sarcoma 232Unsulfated glycan 216UPLC-UV 170Upper concentration limit 217urine 174uterus 232UVB 237

V

validation 225Validation 252, 255validation study 171vedaprofen 188Vibrio parahaemolyticus 201, 206Vibrio vulnificus 206virtual machine 75Virus-Net 256vitamin D receptor 210Vitellogenin 205

Page 10: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)406 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

規格 252器具・容器包装 252規制 256規制科学 246規制値 258寄生虫 256凝集体 249強壮系健康食品 169共有化 198許容ばく露濃度 252グルタミン酸トランスポーター 261経済協力開発機構 265ケイ酸マグネシウム 253化粧品 262結晶化 247結晶多形 246原因不明下痢症 256検査法 255原子吸光光度法 253口腔内崩壊錠 246抗酸化剤 257高次構造 249抗腫瘍効果 257高生産量化学物質 265構造式 253公定書 245, 252後発医薬品 246国際調和試験法 250国際比較 249国際標準化 182コショウ 259混合感染 198剤形 245再生医療機器 182細胞・組織加工製品 176サポウルス 199サルモネラ 259サルモネラ属菌 257酸化ストレス 257残存化学物質 252ジェネリック医薬品品質情報検討会 246塩 259試験法 262指針 251室内環境 256質量分析法 250脂肪酸 259

WHI試験 259α-Synuclein 215β-haptoglobin 168γ-radiation 238δ-guaiene synthase 169

アスピリン 257新しい寄生虫性食中毒 256アパタイト形成 181新たな食中毒 256安全性 177, 178, 249, 262安定性評価 178胃腸炎ウイルス 198一般試験法 246一般用医薬品 251一般用漢方製剤承認基準 250遺伝子型 199遺伝子鑑定 251遺伝子組換えFSH 166遺伝子治療 251遺伝毒性 259, 263, 264医療機器 182飲食物 258ウイルス検査法 198, 255ウイルス検出法 198ウイルス性食中毒 197, 198, 199ウイルス性食中毒 255栄養 259エポエチン アルファ後続品 249塩基配列情報 198買上げ検査 169海外 219ガイドライン 249化学医薬品 246化学物質 258, 259化学薬品 246各条ヘパリンナトリウム 166革新的医薬品 246画像解析 246カビ汚染 256カビ毒 256殻付き卵 259玩具 252感染性胃腸炎 199漢方処方エキス 250漢方製剤 250, 251

Page 11: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

407国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

動物実験の3R 261動物用飼料 259特性解析 249特定原材料 258トレーサビリティ 251ナノDDS 248ナノマテリアル 252ナノメディシン 248生牡蠣 255生シラス 197難溶性医薬品 160日局 245日本薬局方 246, 250乳癌 259ネットワーク 256熱分析 247ノロウイルス 199ノロウイルス食中毒 255バイオ医薬品 249, 250バイオ後続品 249バイオシミラー 249発がん物質 258, 259パラサイトトキシン 256バリデーション 262非晶質 247ヒトES細胞 178ヒトiPS細胞 177ヒト幹細胞 177, 178ヒト体性幹細胞 177ヒト多能性幹細胞 176肥満細胞 258評価 248病原体調査 256非臨床試験 178品質 177, 178, 249, 250品質確保 246品質管理 178, 245, 246品質評価 251フェヌグリーク種子 259ふき取り 198不純物 263, 264物理的化学的性質 249分化誘導肝細胞 261分子変異体 249分析 258分類 245ヘパリン 249

重要品質特性 250宿主細胞由来DNA 249純度試験 166錠剤 245承認基準 251消費者庁 259生薬及び動植物成分のリスク区分 250生薬製剤 250生薬製剤一般用配合剤 250生薬等各条 250食中毒 257食中毒関連病原体 259食中毒傾向 256食中毒調査 255食品 198, 258, 259食品汚染 256食品中の食品添加物分析法 253食品添加物 252食物アレルギー 258食用多糖類ペクチンゲル化 256スプラウト 259製剤総則 246, 250生食 257製造工程由来不純物 249生物学的性質 249生物薬品 250製薬用水 245西洋ハーブ 251専門家判断 259前立腺癌 248掃除機内ダスト 199造腫瘍性 176創薬 246, 257測定 258第16改正日本薬局方 253ダイオキシン汚染 259第十六改正日本薬局方 250大腸菌O104: H4 259体内動態 248中和抗体 249定量NMR 251データの質 259データベース 256デオキシニバレノール 256統合失調症 261同等性 247動物実験代替法 261, 262

Page 12: 国立医薬品食品衛生研究所報告第130号キーワード索引 ...dielectric relaxation time 161 Dietary oil emulsion 214 dilated cardiomyopathy 179 dimethyl fumarate 186

第130号(2012)408 国 立 医 薬 品 食 品 衛 生 研 究 所 報 告

ヘパリンナトリウム 250崩壊試験法 246放射線 258放射能 258ホームページ 258骨組織適合性 181ホルモン療法 259マイコトキシン 256マイコプラズマ試験 250慢性疲労症候群 248無承認無許可医薬品 169名称 253目的物質由来不純物 249薬局方 245, 249有害性試験 252有症苦情事例 197溶出試験 160溶出性 246ラウリル硫酸ナトリウム 160理化学試験法 246理化学試験用ヘパリンナトリウム標準品 166リスク評価 249, 258, 259リポソーム製剤 247臨床応用 248臨床試験 178臨床評価 166ルシフェラーゼ 258レギュラトリーサイエンス 166, 261レトロウイルス 248